Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Apyx Medical Corporation

APYXNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Jun 15, 2026Accepted Jun 15, 2026, 7:00 PM EDTFiling CIK 719135Accession 0001493152-26-028765
Share

Structured filing — 4

ownership.xml

Open full document ↗

Filing details

Report period
2026-06-11
Issuer
Apyx Medical Corp
Issuer CIK
0000719135
Trading symbol
APYX

Reporting owner 1

Name
CITRONOWICZ MOSHE
Reporting owner CIK
0001280851
Relationship
Officer
Officer title
Sr. V.P. of Operations
Address
C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER, FL, 33760

Derivative transactions

Derivative transactions · 1 reported row
SecurityConversion / exercise price (USD)Transaction dateCodeAmountA / DPrice (USD)ExercisableExpiresUnderlying securityUnderlying sharesOwned afterOwnership
Stock Option (Option to Buy)4.652026-06-11A · Form 463,392A0[F1]2036-06-11Common Stock63,39263,392D
Table key
A · Form 4
Acquisition by grant, award or otherwise under Rule 16b-3(d)
A
Acquired
D
Direct

Footnotes

F1
Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.↩ 1

Signature 1

Signed
/s/ Moshe Citronowicz
Date
2026-06-15

Company context

Current securities

Recent company filings

  1. Other EventsSep 29, 2026
  2. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Submission of Matters to a Vote of Security HoldersAug 7, 2026
  3. 10-Q filingAug 6, 2026
  4. Results of Operations and Financial ConditionAug 6, 2026
  5. Other EventsJul 24, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.